Check out the companies making headlines before the bell: UiPath — Shares surged 12% after the automation software company posted first-quarter operating income and revenue figures that exceeded FactSet estimates. UiPath also raised its full-year revenue guidance and sees its current-quarter revenue coming in between $345 million and $350 million, while analysts polled by FactSet…
Check out the companies making headlines in midday trading. UnitedHealth — The health insurer’s stock popped roughly 7% as investors scooped up shares of the beaten-down name, which lost 23% last week. UnitedHealth had suspended its 2025 guidance, announced that its CEO is stepping down and is reportedly the subject of a U.S. Department of…
Check out the companies making headlines in midday trading. AppLovin — The mobile ad tech company jumped 12% after first-quarter results that beat analyst expectations. AppLovin also announced it would sell its mobile gaming business in a $400 million deal. Carvana — Shares jumped more than 11% after the online used car marketplace posted better-than-expected…
Check out the companies making headlines in midday trading: Spotify — Shares of the music streaming company lost 3.5% on the back of disappointing results. Spotify reported first-quarter operating income of 509 million euros, while analysts polled by FactSet expected 519.9 million euros. Spotify’s revenue of 4.2 billion euros was in line with estimates, while…
Check out the companies making headlines in midday trading: Spotify — Shares of the music streaming company lost 3.5% on the back of disappointing results. Spotify reported first-quarter operating income of 509 million euros, while analysts polled by FactSet expected 519.9 million euros. Spotify’s revenue of 4.2 billion euros was in line with estimates, while…
The Lilly Biotechnology Center in San Diego, California, on March 1, 2023. Mike Blake | Reuters Shares of drugmakers fell on Wednesday after President Donald Trump doubled down on plans to impose tariffs on pharmaceuticals imported into the U.S. Shares of U.S.-based companies Eli Lilly, AbbVie, Bristol Myers Squibb and Regeneron all fell about 4%…
